NeuroOne is a medical technology company focused on improving surgical care for patients suffering from neurological disorders.
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 3, 2022 | Post-IPO Debt | $10.50M | 1 | Zimmer Biomet | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Zimmer Biomet | Yes | Post-IPO Debt |